Reply to a fibrinolysis-first strategy for ST-elevation myocardial infarction in the COVID-19 era

Int J Cardiol. 2021 Nov 15:343:199. doi: 10.1016/j.ijcard.2021.09.043. Epub 2021 Sep 25.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • COVID-19*
  • Fibrinolysis
  • Fibrinolytic Agents / therapeutic use
  • Humans
  • SARS-CoV-2
  • ST Elevation Myocardial Infarction* / drug therapy
  • ST Elevation Myocardial Infarction* / therapy
  • Thrombolytic Therapy

Substances

  • Fibrinolytic Agents